# NAD Supplementation Study

> **NCT03310034** · NA · TERMINATED · sponsor: **Maastricht University** · enrollment: 14 (actual)

## Conditions studied

- Aging
- Mitochondrial Function

## Interventions

- **DIETARY_SUPPLEMENT:** NAD-precursors
- **DIETARY_SUPPLEMENT:** Control

## Key facts

- **NCT ID:** NCT03310034
- **Lead sponsor:** Maastricht University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-11-01
- **Primary completion:** 2020-03-06
- **Final completion:** 2020-03-06
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Concluded study following COVID19 outbreak and inability to complete study as designed.
- **Last updated:** 2020-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03310034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03310034, "NAD Supplementation Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03310034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*